These days, product recalls are nothing out of the ordinary. From children’s toys to Tylenol, you locate the offending item, send in your receipt, and with any luck, get a refund. But when the recall in question concerns a breast implant – as it does right now in a scandal here in the U.K. – then the process is a quite bit more complicated.
In case you haven’t heard, silicone breast implants made with P.I.P. – an industrial grade silicone – by a French company have now been declared faulty, exposing women to ruptures, leaks and possible risks of cancer. Over the past 12 years, some 300,000 of these implants were sold to women around the globe in more than 65 countries, predominantly in Europe and South America. (The United States banned this product and declared it unsafe.)
The French government has recently recalled all P.I.P. implants and agreed to pay for their removal, but only for women who’d had the original surgery done in France. The British government maintains that the link between P.I.P. implants and cancer is far lower than suggested by French data. It has agreed to pay for any removal on implants performed by the National Health Service (NHS) over the past decade (primarily those linked to breast cancer reconstructive surgery). But this accounts for only about 5% of the 40,000 women who’ve had implants in this country during that time.
As for the remaining 38,000 or so cases, the government is urging private clinics to perform the recalls for free on moral grounds. (As a last resort, the government will step in to pay for removal of implants put in in a private clinic that has closed or is unwilling to provide the service.
And this is where things get interesting.
Read the rest of this story at The Washington Post’s She The People Blog…
Image: breast implant 5 by matthewlucas via Flickr under a Creative Commons license